Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 35 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

3%

1 of 30 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
21(72.4%)
Phase 2
3(10.3%)
Phase 3
2(6.9%)
Phase 4
2(6.9%)
Phase 1
1(3.4%)
29Total
N/A(21)
Phase 2(3)
Phase 3(2)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials
NCT02174666Not ApplicableCompleted

Isoflavone Treatment for Postmenopausal Osteopenia.

Role: collaborator

NCT01732705Not ApplicableCompleted

High Intensity Interval Training (HIT) in Patients With Type 2 Diabetes

Role: collaborator

NCT01411527Completed

The COPENHAGEN Puberty Study

Role: collaborator

NCT03365817Phase 3Completed

Cognitive Function and Addiction Under Opioid Tapering

Role: collaborator

NCT01542164Completed

Calcium Intake and Fat Excretion

Role: collaborator

NCT01698151Unknown

Prognosis and Treatment of COPD in Primary Care-use of Biomarkers

Role: collaborator

NCT01762540Phase 2Completed

Glucocorticoid Induced Whole Body Catabolisme

Role: collaborator

NCT01389193Phase 1Completed

Ibudilast in the Treatment of Patients With Chronic Migraine.

Role: collaborator

NCT01464801Not ApplicableCompleted

Resveratrol in Patients With Non-alcoholic Fatty Liver Disease

Role: collaborator

NCT02177097Completed

Chronic Pain, Inflammation and Infection After Joint Replacement

Role: collaborator

NCT01803061Not ApplicableCompleted

Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care

Role: collaborator

NCT00722475Phase 3Completed

Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage

Role: collaborator

NCT02147535Phase 4Completed

Impact of CES1 Genotype on Metabolism of Methylphenidate

Role: collaborator

NCT02135263Phase 4Completed

Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype

Role: collaborator

NCT01199835Not ApplicableCompleted

The Effects of Dairy Products on Energy Balance

Role: collaborator

NCT01446276Not ApplicableCompleted

Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease

Role: collaborator

NCT01434264Not ApplicableCompleted

Evaluating Personalized Effect of an Individualized Intervention

Role: collaborator

NCT01693237Phase 2Unknown

Improving Patient Outcome in Group Therapy for Eating Disorders

Role: collaborator

NCT01826279Not ApplicableUnknown

Short-term Investigation of Resveratrol on Fat Metabolism in Morbidly Obese Women Undergoing Gastric Bypass Surgery

Role: collaborator

NCT01412645Not ApplicableCompleted

Long-term Investigation of Resveratrol in Obesity

Role: collaborator